Citi is out with its report today on Clorox CLX, lowering its PT from $71 to $69.
In its report, Citi writes, "CLX continues to be impacted by weak category growth and input cost pressures. With the stock trading ahead of its fundamentals (boosted by Icahn's proposed takeover), we maintain our Hold rating and are lowering our target price to $69 to reflect Icahn's reduced offer price for the company (from $80 a share, to $78)."
At the time of posting, shares of CLX were trading pre-market at $68.04, down 1.41% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in